293 related articles for article (PubMed ID: 1309967)
1. Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. tuberculosis and their penetration into mouse peritoneal macrophages.
Dhillon J; Mitchison DA
Am Rev Respir Dis; 1992 Jan; 145(1):212-4. PubMed ID: 1309967
[TBL] [Abstract][Full Text] [Related]
2. Activity and penetration of antituberculosis drugs in mouse peritoneal macrophages infected with Mycobacterium microti OV254.
Dhillon J; Mitchison DA
Antimicrob Agents Chemother; 1989 Aug; 33(8):1255-9. PubMed ID: 2802553
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria.
Dickinson JM; Mitchison DA
Tubercle; 1987 Sep; 68(3):177-82. PubMed ID: 2834842
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis.
Heifets LB; Lindholm-Levy PJ; Flory MA
Am Rev Respir Dis; 1990 Mar; 141(3):626-30. PubMed ID: 2155555
[TBL] [Abstract][Full Text] [Related]
5. In vitro observations on the suitability of new rifamycins for the intermittent chemotherapy of tuberculosis.
Dickinson JM; Mitchison DA
Tubercle; 1987 Sep; 68(3):183-93. PubMed ID: 2834843
[TBL] [Abstract][Full Text] [Related]
6. Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCG.
Rastogi N; Goh KS; Berchel M; Bryskier A
J Antimicrob Chemother; 2000 Oct; 46(4):565-70. PubMed ID: 11020253
[TBL] [Abstract][Full Text] [Related]
7. Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis.
Heifets LB; Lindholm-Levy PJ; Iseman MD
Am Rev Respir Dis; 1988 Mar; 137(3):719-21. PubMed ID: 2830815
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.
Woodley CL; Kilburn JO
Am Rev Respir Dis; 1982 Sep; 126(3):586-7. PubMed ID: 6289711
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complex.
Klemens SP; Grossi MA; Cynamon MH
Antimicrob Agents Chemother; 1994 Feb; 38(2):234-7. PubMed ID: 8192449
[TBL] [Abstract][Full Text] [Related]
10. [In vitro activities of rifabutine and rifampicin against various mycobacteria, especially Mycobacterium tuberculosis and Mycobacterium avium complex].
Saito H; Sato K; Tomioka H
Kekkaku; 1988 Mar; 63(3):167-72. PubMed ID: 2836649
[No Abstract] [Full Text] [Related]
11. The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis.
Chan SL; Yew WW; Ma WK; Girling DJ; Aber VR; Felmingham D; Allen BW; Mitchison DA
Tuber Lung Dis; 1992 Feb; 73(1):33-8. PubMed ID: 1326348
[TBL] [Abstract][Full Text] [Related]
12. The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis.
Sirgel FA; Fourie PB; Donald PR; Padayatchi N; Rustomjee R; Levin J; Roscigno G; Norman J; McIlleron H; Mitchison DA
Am J Respir Crit Care Med; 2005 Jul; 172(1):128-35. PubMed ID: 15805182
[TBL] [Abstract][Full Text] [Related]
13. Activity of two long-acting rifamycins, rifapentine and FCE 22807, in experimental murine tuberculosis.
Dhillon J; Dickinson JM; Guy JA; Ng TK; Mitchison DA
Tuber Lung Dis; 1992 Apr; 73(2):116-23. PubMed ID: 1643297
[TBL] [Abstract][Full Text] [Related]
14. [Comparative in vitro activities of rifabutin and rifampicin against various mycobacteria using 7H10 agar and 1% Ogawa egg media].
Sato K; Saito H; Tomioka H
Kekkaku; 1988 Sep; 63(9):601-4. PubMed ID: 2854588
[No Abstract] [Full Text] [Related]
15. Comparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophages.
Mor N; Simon B; Mezo N; Heifets L
Antimicrob Agents Chemother; 1995 Sep; 39(9):2073-7. PubMed ID: 8540718
[TBL] [Abstract][Full Text] [Related]
16. [Activities of rifabutine and rifampicin against Mycobacterium avium complex infections in mice and in peritoneal macrophages].
Saito H; Sato K; Tomioka H
Kekkaku; 1988 Mar; 63(3):173-9. PubMed ID: 2836650
[No Abstract] [Full Text] [Related]
17. Immunodeficiency and Intermittent Dosing Promote Acquired Rifamycin Monoresistance in Murine Tuberculosis.
Park SW; Tasneen R; Converse PJ; Nuermberger EL
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874368
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice.
Ji B; Truffot-Pernot C; Lacroix C; Raviglione MC; O'Brien RJ; Olliaro P; Roscigno G; Grosset J
Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1541-6. PubMed ID: 8256897
[TBL] [Abstract][Full Text] [Related]
19. In vivo activities of newer rifamycin analogs against Mycobacterium avium infection.
Klemens SP; Cynamon MH
Antimicrob Agents Chemother; 1991 Oct; 35(10):2026-30. PubMed ID: 1662021
[TBL] [Abstract][Full Text] [Related]
20. [Study of the minimal inhibitory concentration of rifabutine (Ansamycin LM 427) for Mycobacterium tuberculosis, Mycobacterium xenopi and Mycobacterium avium-intracellulare].
Truffot-Pernot C; Giroir AM; Maury L; Grosset J
Rev Mal Respir; 1988; 5(4):401-6. PubMed ID: 2845531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
